CD8A and neoplasm: Furthermore, to evaluate the role of neoantigen-specific CD8+ T cells in tumor immunity, they implanted WHIM30 tumor sections into immune-compromised mice and adoptively transferred autologous PBMCs stimulated with PALB2, ROBO3, or CMV peptides.